The Medical Science Liaison will serve as a field-based scientific expert, building peer-to-peer relationships with key opinion leaders and healthcare professionals in oncology. They will gather clinical insights, support research initiatives, and ensure scientific communications are accurate and strategically aligned with company goals.
The Medical Director will provide clinical development leadership for clinical-stage assets, serving as a medical monitor and overseeing clinical trial data review. They will also contribute to regulatory document authorship, strategic planning, and cross-functional collaboration with internal and external stakeholders.
The Vice President of Pharmacovigilance will lead global drug safety strategy, ensuring regulatory compliance and proactive benefit-risk assessment for all products. This executive will oversee safety governance, signal management, and the development of a high-performing safety organization.
The Territory Manager is responsible for driving commercial performance by developing relationships with oncology healthcare providers and executing brand strategy. They must manage territory business plans, deliver clinical education, and collaborate cross-functionally to support patient access while maintaining strict compliance.
The Vice President of Pharmacovigilance will lead global drug safety strategy, ensuring regulatory compliance and proactive benefit-risk assessment for all products. They will oversee safety governance, signal management, and the development of a high-performing organization while partnering across clinical and commercial functions.
Provide clinical development leadership for early and late-stage assets, serving as a medical monitor and authoring key regulatory documents. Foster collaboration across functions and manage relationships with key opinion leaders to advance product candidates.
Develop and execute a strategic territory business plan to support the launch of tirabrutinib for PCNSL patients. Build strong relationships with hematology/oncology healthcare professionals and collaborate cross-functionally to ensure patient access and product readiness.
Develop and execute a strategic territory business plan to support the launch of tirabrutinib for PCNSL patients. Build strong relationships with hematology/oncology healthcare professionals and collaborate cross-functionally to ensure patient access and product readiness.
